NCT00000782View on ClinicalTrials.gov

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1996

Conditions

HIV Infections

Interventions

BIOLOGICAL

gp160 Vaccine (Immuno-AG)

BIOLOGICAL

gp160 Vaccine (MicroGeneSys)

Trial Locations (4)

10016

NY Univ. HIV/AIDS CRS, New York

943055107

Stanford CRS, Palo Alto

San Mateo County AIDS Program, San Mateo

951282699

Santa Clara Valley Med. Ctr., San Jose

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000782 - A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen | Biotech Hunter | Biotech Hunter